DCHS1
Basic information
Region (hg38): 11:6621330-6655809
Previous symbols: [ "CDH25", "PCDH16" ]
Links
Phenotypes
GenCC
Source:
- van Maldergem syndrome 1 (Strong), mode of inheritance: AR
- familial mitral valve prolapse (Supportive), mode of inheritance: AD
- van Maldergem syndrome (Supportive), mode of inheritance: AR
- mitral valve prolapse, myxomatous 2 (Strong), mode of inheritance: AD
- van Maldergem syndrome 1 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Mitral valve prolapse 2; Van Maldegrem syndrome 1 | AD/AR | Audiologic/Otolaryngologic; Cardiovascular | For Mitral valve prolapse, individuals may manifest with severe mitral valve prolapse leading to heart failure and requiring surgery, and awareness may allow prompt diagnosis and management; For Van Maldegrem syndrome, early recognition and treatment of hearing impairment may improve outcomes, including speech and language development | Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Musculoskeletal; Neurologic; Renal | 12707861; 24056717; 26258302 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (11 variants)
- Mitral valve prolapse, myxomatous 2 (2 variants)
- Van Maldergem syndrome 1 (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DCHS1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 442 | 27 | 478 | |||
missense | 978 | 50 | 17 | 1046 | ||
nonsense | 15 | |||||
start loss | 0 | |||||
frameshift | 10 | |||||
inframe indel | 8 | |||||
splice donor/acceptor (+/-2bp) | 2 | |||||
splice region | 17 | 25 | 3 | 45 | ||
non coding | 66 | 22 | 92 | |||
Total | 14 | 5 | 1006 | 559 | 67 |
Highest pathogenic variant AF is 0.0000329
Variants in DCHS1
This is a list of pathogenic ClinVar variants found in the DCHS1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-6621526-TGAG-T | Likely benign (Oct 09, 2018) | |||
11-6621604-C-T | Likely benign (Apr 14, 2019) | |||
11-6621791-C-G | Uncertain significance (Dec 10, 2022) | |||
11-6621793-C-G | Inborn genetic diseases | Uncertain significance (Nov 10, 2021) | ||
11-6621794-C-T | DCHS1-related disorder | Likely benign (May 19, 2023) | ||
11-6621795-G-A | Uncertain significance (Dec 07, 2023) | |||
11-6621797-G-A | Likely benign (Nov 15, 2023) | |||
11-6621806-T-C | Likely benign (May 30, 2023) | |||
11-6621810-T-A | Uncertain significance (Dec 09, 2023) | |||
11-6621817-C-A | Uncertain significance (Jan 09, 2024) | |||
11-6621826-C-T | Likely benign (Mar 13, 2023) | |||
11-6621827-G-A | Likely benign (Nov 19, 2023) | |||
11-6621832-G-C | Inborn genetic diseases | Uncertain significance (Feb 15, 2023) | ||
11-6621835-C-A | Uncertain significance (Dec 11, 2021) | |||
11-6621837-G-A | Uncertain significance (Mar 10, 2023) | |||
11-6621842-T-C | Likely benign (Jan 06, 2024) | |||
11-6621852-T-C | Uncertain significance (Nov 02, 2023) | |||
11-6621872-G-A | Likely benign (Feb 02, 2022) | |||
11-6621877-C-T | Uncertain significance (Jan 19, 2024) | |||
11-6621878-G-A | Likely benign (Sep 12, 2022) | |||
11-6621879-G-A | Conflicting classifications of pathogenicity (Jan 21, 2024) | |||
11-6621882-G-A | Uncertain significance (Oct 12, 2020) | |||
11-6621885-C-T | Inborn genetic diseases | Uncertain significance (Dec 19, 2023) | ||
11-6621886-G-A | Inborn genetic diseases | Uncertain significance (Nov 27, 2023) | ||
11-6621889-C-T | Inborn genetic diseases | Uncertain significance (Aug 28, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
DCHS1 | protein_coding | protein_coding | ENST00000299441 | 20 | 34530 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.0000290 | 125563 | 0 | 30 | 125593 | 0.000119 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.40 | 1630 | 1.93e+3 | 0.846 | 0.000125 | 20449 |
Missense in Polyphen | 571 | 776.79 | 0.73507 | 8914 | ||
Synonymous | 1.50 | 756 | 810 | 0.933 | 0.0000505 | 7695 |
Loss of Function | 7.64 | 15 | 95.6 | 0.157 | 0.00000637 | 978 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000210 | 0.000210 |
Ashkenazi Jewish | 0.000299 | 0.000298 |
East Asian | 0.0000648 | 0.0000544 |
Finnish | 0.000239 | 0.000231 |
European (Non-Finnish) | 0.000111 | 0.000106 |
Middle Eastern | 0.0000648 | 0.0000544 |
South Asian | 0.000152 | 0.000131 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Calcium-dependent cell-adhesion protein. Mediates functions in neuroprogenitor cell proliferation and differentiation. In the heart, has a critical role for proper morphogenesis of the mitral valve, acting in the regulation of cell migration involved in valve formation (PubMed:26258302). {ECO:0000269|PubMed:26258302}.;
- Disease
- DISEASE: Mitral valve prolapse 2 (MVP2) [MIM:607829]: A form of mitral valve prolapse, a valvular hearth disease characterized by abnormally elongated and thickened mitral valve leaflets, that typically show myxomatous degeneration with increased leaflet compliance. It is associated with mitral regurgitation. Myxomatous mitral valves have an abnormal layered architecture characterized by loose collagen in fibrosa, expanded spongiosa strongly positive for proteoglycans, and disrupted elastin in atrialis. In classic mitral valve prolapse, leaflets are at least 5 mm thick, whereas in the non-classic form, they are less than 5 mm thick. Severe classic mitral valve prolapse is strongly associated with arrhythmias, endocarditis, heart failure, and need for valve surgery. {ECO:0000269|PubMed:26258302}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Hippo signaling pathway - multiple species - Homo sapiens (human)
(Consensus)
Recessive Scores
- pRec
- 0.131
Intolerance Scores
- loftool
- 0.261
- rvis_EVS
- -1.38
- rvis_percentile_EVS
- 4.4
Haploinsufficiency Scores
- pHI
- 0.330
- hipred
- Y
- hipred_score
- 0.623
- ghis
- 0.529
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.580
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Dchs1
- Phenotype
- growth/size/body region phenotype; respiratory system phenotype; embryo phenotype; renal/urinary system phenotype; skeleton phenotype; digestive/alimentary phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Zebrafish Information Network
- Gene name
- dchs1b
- Affected structure
- fertilized egg
- Phenotype tag
- abnormal
- Phenotype quality
- disoriented
Gene ontology
- Biological process
- branching involved in ureteric bud morphogenesis;mitral valve formation;cell migration involved in endocardial cushion formation;homophilic cell adhesion via plasma membrane adhesion molecules;heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules;pattern specification process;calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules;neural tube development;neurogenesis;hippo signaling;post-anal tail morphogenesis;ossification involved in bone maturation;digestive tract development;condensed mesenchymal cell proliferation;protein localization to plasma membrane;cochlea development
- Cellular component
- plasma membrane;membrane;integral component of membrane;apical part of cell
- Molecular function
- calcium ion binding